Carter Robert Ross 4
4 · Oncology Institute, Inc. · Filed Mar 20, 2025
Insider Transaction Report
Form 4
Carter Robert Ross
Chief Financial Officer
Transactions
- Disposition to Issuer
Class A Common Stock
2025-03-19$0.89/sh−1,150$1,022→ 30,351 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.